Product Information
BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2072 per EA under NDC 00093324356. Its NADAC has been published 351 times since Oct 9, 2019.
BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB
bisoprolol fumarate and hydrochlorothiazideStrength
10; 6.25 mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093324356
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020186On Market Since
8/7/2019
Pharmacological Classes
Price Statistics
The NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB has been published 351 times since Oct 9, 2019, and over the history we have for it it has declined 56.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2072 per EA |
|---|---|
| All-time high | $0.4753 (Oct 16, 2019) |
| All-time low | $0.1227 (Nov 20, 2024) |
| 52-week high | $0.2242 |
| 52-week low | $0.2038 |
| Median price | $0.2858 |
| Average price | $0.3047 |
| Largest weekly change | +49.9% (Dec 18, 2024) |
| Weeks tracked | 351 |
| Tracking since | Oct 9, 2019 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB, manufactured by Teva Pharmaceuticals USA Inc., is $0.2072 per EA (NDC 00093324356), effective Jun 24, 2026.
How has the price of BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB changed over time?
Over the history we have for it, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB has declined 56.4%. It has been tracked across 351 weekly CMS publications since Oct 9, 2019.
What are the highest and lowest recorded NADAC prices for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?
Since Oct 9, 2019, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB has ranged from a low of $0.1227 (Nov 20, 2024) to a high of $0.4753 (Oct 16, 2019), with a median of $0.2858 per EA.
Are there cheaper alternatives to BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?
3 NADAC-published products share the same active ingredient, strength, and dosage form as BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB, but none are currently priced below it.
Who manufactures BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?
BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB (NDC 00093324356) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification